Format

Send to

Choose Destination
JAMA. 2019 Nov 15. doi: 10.1001/jama.2019.18587. [Epub ahead of print]

Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations.

Author information

1
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.
2
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
3
Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
PMID:
31730152
DOI:
10.1001/jama.2019.18587

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center